The solute carrier family 10 (SLC10): Beyond bile acid transport

Molecular Aspects of Medicine

Volumn 34, Issue 2-3, 2013, Pages 252-269

  Claro Da Silva, Tatiana ^a   Polli, James E ^a   Swaan, Peter W ^a  

^a UNIVERSITY OF MARYLAND   (United States)

Author keywords

ASBT; Bile acid; NTCP; SLC10; SOAT; TGR5

Indexed keywords

1 (3,4 DIMETHOXYPHENYL) 3 (3 ETHYLVALERYL) 4 HYDROXY 6,7,8 TRIMETHOXY 2 NAPHTHOIC ACID METHYL ESTER; 264W 94; 3 BUTYL 3 ETHYL 2,3,4,5 TETRAHYDRO 7,8 DIMETHOXY 5 PHENYL 1,4 BENZOTHIAZEPINE 1,1 DIOXIDE; A 3309; ACICLOVIR; AMPICILLIN; APICAL SODIUM DEPENDENT BILE ACID TRANSPORTER; BILE ACID; CALCITRIOL; CALCIUM CHANNEL BLOCKING AGENT; CARRIER PROTEIN; DOXERCALCIFEROL; ERGOCALCIFEROL; G PROTEIN COUPLED BILE ACID RECEPTOR 1; G PROTEIN COUPLED RECEPTOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; METHYLPREDNISOLONE; PR 835; PROTEIN INHIBITOR; PROTEIN P3; PROTEIN P4; PROTEIN P5; PROTEIN P7; SC 435; SODIUM DEPENDENT ORGANIC ANION TRANSPORTER; SODIUM TAUROCHOLATE COTRANSPORTING POLYPEPTIDE; SOLUTE CARRIER PROTEIN 10; SOLUTE CARRIER PROTEIN 10A7; TAUROURSODEOXYCHOLIC ACID; UNCLASSIFIED DRUG; URSODEOXYCHOLIC ACID;

BARRETT ESOPHAGUS; BILE ACID TRANSPORT; CHOLESTASIS; CONSTIPATION; CROHN DISEASE; DIABETES MELLITUS; DIGESTIVE SYSTEM CANCER; DYSLIPIDEMIA; ENTERITIS; GENE; GENE EXPRESSION REGULATION; GENE FUNCTION; GENETIC CODE; GENETIC VARIABILITY; HUMAN; HYPERLIPIDEMIA; HYPERPARATHYROIDISM; INSULIN RESISTANCE; LIPID TRANSPORT; NECROTIZING ENTEROCOLITIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUCLEOTIDE SEQUENCE; OSTEOPOROSIS; PRIMARY SCLEROSING CHOLANGITIS; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN POLYMORPHISM; REVIEW; SLC10 GENE; SLC10A1 GENE; SLC10A2 GENE; SLC10A3 GENE; SLC10A4 GENE; SLC10A45 GENE; SLC10A6 GENE; SLC10A7 GENE; TRANSCRIPTION REGULATION;

BILE ACIDS AND SALTS; GENETIC VARIATION; GONADAL STEROID HORMONES; HUMANS; MODELS, BIOLOGICAL; MODELS, MOLECULAR; MULTIGENE FAMILY; ORGANIC ANION TRANSPORTERS, SODIUM-DEPENDENT; PROTEIN CONFORMATION; SYMPORTERS;

EID: 84875184450     PISSN: 00982997     EISSN: 18729452     Source Type: Journal    
DOI: 10.1016/j.mam.2012.07.004     Document Type: Review

References (122)

1. M. Ananthanarayanan, Y. Li, S. Surapureddi, N. Balasubramaniyan, J. Ahn, J.A. Goldstein, and F.J. Suchy Histone H3K4 trimethylation by MLL3 as part of ASCOM complex is critical for NR activation of bile acid transporter genes and is downregulated in cholestasis Am. J. Physiol. Gastrointest. Liver Physiol. 300 5 2011 G771 781
2. P. Anderle, T. Sengstag, D.M. Mutch, M. Rumbo, V. Praz, R. Mansourian, M. Delorenzi, G. Williamson, and M.A. Roberts Changes in the transcriptional profile of transporters in the intestine along the anterior-posterior and crypt-villus axes BMC Genomics 6 2005 69
3. F. Annaba, P. Kumar, A.K. Dudeja, S. Saksena, R.K. Gill, and W.A. Alrefai Green tea catechin EGCG inhibits ileal apical sodium bile acid transporter ASBT Am. J. Physiol. Gastrointest. Liver Physiol. 298 3 2010 G467 473
4. F. Annaba, K. Ma, P. Kumar, A.K. Dudeja, R.D. Kineman, B.L. Shneider, S. Saksena, R.K. Gill, and W.A. Alrefai Ileal apical Na+-dependent bile acid transporter ASBT is upregulated in rats with diabetes mellitus induced by low doses of streptozotocin Am. J. Physiol. Gastrointest. Liver Physiol. 299 4 2010 G898 906
5. F. Annaba, Z. Sarwar, P. Kumar, S. Saksena, J.R. Turner, P.K. Dudeja, R.K. Gill, and W.A. Alrefai Modulation of ileal bile acid transporter (ASBT) activity by depletion of plasma membrane cholesterol: association with lipid rafts Am. J. Physiol. Gastrointest. Liver Physiol. 294 2 2008 G489 497
6. A. Balakrishnan, and J.E. Polli Apical sodium dependent bile acid transporter (ASBT, SLC10A2): a potential prodrug target Mol. Pharm. 3 3 2006 223 230
7. A. Balakrishnan, S.A. Wring, and J.E. Polli Interaction of native bile acids with human apical sodium-dependent bile acid transporter (hASBT): influence of steroidal hydroxylation pattern and C-24 conjugation Pharm. Res. 23 7 2006 1451 1459
8. S. Balesaria, R.J. Pell, L.J. Abbott, A. Tasleem, K.M. Chavele, N.F. Barley, U. Khair, A. Simon, K.J. Moriarty, W.G. Brydon, and J.R. Walters Exploring possible mechanisms for primary bile acid malabsorption: evidence for different regulation of ileal bile acid transporter transcripts in chronic diarrhoea Eur. J. Gastroenterol. Hepatol. 20 5 2008 413 422
9. A. Banerjee, N. Hussainzada, A. Khandelwal, and P.W. Swaan Electrostatic and potential cation-pi forces may guide the interaction of extracellular loop III with Na+ and bile acids for human apical Na+-dependent bile acid transporter Biochem. J. 410 2 2008 391 400
10. M. Begley, C.G. Gahan, and C. Hill The interaction between bacteria and bile FEMS Microbiol. Rev. 29 4 2005 625 651
11. C. Bernstein, H. Holubec, A.K. Bhattacharyya, H. Nguyen, C.M. Payne, B. Zaitlin, and H. Bernstein Carcinogenicity of deoxycholate, a secondary bile acid Arch. Toxicol. 85 8 2011 863 871
12. H. Bernstein, C. Bernstein, C.M. Payne, and K. Dvorak Bile acids as endogenous etiologic agents in gastrointestinal cancer World J. Gastroenterol. 15 27 2009 3329 3340
13. I.T. Bijsmans, R.A. Bouwmeester, J. Geyer, K.N. Faber, and S.F. van de Graaf Homo- and hetero-dimeric architecture of the human liver Na(+)-dependent taurocholate co-transporting protein Biochem. J. 441 3 2012 1007 1015
14. S. Burger, B. Doring, M. Hardt, K. Beuerlein, R. Gerstberger, and J. Geyer Co-expression studies of the orphan carrier protein Slc10a4 and the vesicular carriers VAChT and VMAT2 in the rat central and peripheral nervous system Neuroscience 193 2011 109 121
15. R. Cao, Z.X. Cronk, W. Zha, L. Sun, X. Wang, Y. Fang, E. Studer, H. Zhou, W.M. Pandak, P. Dent, G. Gil, and P.B. Hylemon Bile acids regulate hepatic gluconeogenic genes and farnesoid X receptor via G(alpha)i-protein-coupled receptors and the AKT pathway J. Lipid Res. 51 8 2010 2234 2244
16. V. Cattori, U. Eckhardt, and B. Hagenbuch Molecular cloning and functional characterization of two alternatively spliced Ntcp isoforms from mouse liver1 Biochim. Biophys. Acta 1445 1 1999 154 159
17. F. Chen, A.B. Shyu, and B.L. Shneider Hu antigen R and tristetraprolin: counter-regulators of rat apical sodium-dependent bile acid transporter by way of effects on messenger RNA stability Hepatology 54 4 2011 1371 1378
18. L. Chen, X. Yao, A. Young, J. McNulty, D. Anderson, Y. Liu, C. Nystrom, D. Croom, S. Ross, J. Collins, D. Rajpal, K. Hamlet, C. Smith, and B. Gedulin Inhibition of apical sodium-dependent bile acid transporter as a novel treatment for diabetes Am. J. Physiol. Endocrinol. Metab. 302 1 2012 E68 76
19. L. Cheng, W. Lu, B. Kulkarni, T. Pejovic, X. Yan, J.H. Chiang, L. Hood, K. Odunsi, and B. Lin Analysis of chemotherapy response programs in ovarian cancers by the next-generation sequencing technologies Gynecol. Oncol. 117 2 2010 159 169
20. L. Cheng, L. Zhao, D. Li, Z. Liu, G. Chen, F. Tian, X. Li, and S. Wang Role of cholangiocyte bile acid transporters in large bile duct injury after rat liver transplantation Transplantation 90 2 2010 127 134
21. X. Cheng, and C.D. Klaassen Tissue distribution, ontogeny, and hormonal regulation of xenobiotic transporters in mouse kidneys Drug Metab. Dispos. 37 11 2009 2178 2185
22. W.D. Chey, M. Camilleri, L. Chang, L. Rikner, and H. Graffner A randomized placebo-controlled phase IIb trial of a3309, a bile acid transporter inhibitor, for chronic idiopathic constipation Am. J. Gastroenterol. 106 10 2011 1803 1812
23. M.K. Choi, H.J. Shin, Y.L. Choi, J.W. Deng, J.G. Shin, and I.S. Song Differential effect of genetic variants of Na(+)-taurocholate co-transporting polypeptide (NTCP) and organic anion-transporting polypeptide 1B1 (OATP1B1) on the uptake of HMG-CoA reductase inhibitors Xenobiotica 41 1 2011 24 34
24. E.C. Chow, M. Sondervan, C. Jin, G.M. Groothuis, and K.S. Pang Comparative effects of doxercalciferol (1alpha-hydroxyvitamin D(2)) versus calcitriol (1alpha,25-dihydroxyvitamin D(3)) on the expression of transporters and enzymes in the rat in vivo J. Pharm. Sci. 100 4 2011 1594 1604
25. E.C. Chow, H. Sun, A.A. Khan, G.M. Groothuis, and K.S. Pang Effects of 1alpha,25-dihydroxyvitamin D3 on transporters and enzymes of the rat intestine and kidney in vivo Biopharm. Drug Dispos. 31 1 2010 91 108
26. S. Cipriani, A. Mencarelli, M.G. Chini, E. Distrutti, B. Renga, G. Bifulco, F. Baldelli, A. Donini, and S. Fiorucci The bile acid receptor GPBAR-1 (TGR5) modulates integrity of intestinal barrier and immune response to experimental colitis PLoS One 6 10 2011 e25637
27. T. Claudel, G. Zollner, M. Wagner, and M. Trauner Role of nuclear receptors for bile acid metabolism, bile secretion, cholestasis, and gallstone disease Biochim. Biophys. Acta 1812 8 2011 867 878
28. C. Combet, C. Blanchet, C. Geourjon, and G. Deleage NPS@: network protein sequence analysis Trends Biochem. Sci. 25 3 2000 147 150
29. S. Coon, R. Kekuda, P. Saha, and U. Sundaram Glucocorticoids differentially regulate Na-bile acid cotransport in normal and chronically inflamed rabbit ileal villus cells Am. J. Physiol. Gastrointest. Liver Physiol. 298 5 2010 G675 682
30. T.C. da Silva, N. Hussainzada, C.M. Khantwal, J.E. Polli, and P.W. Swaan Transmembrane helix 1 contributes to substrate translocation and protein stability of bile acid transporter SLC10A2 J. Biol. chem. 286 31 2011 27322 27332
31. P.A. Dawson Role of the intestinal bile acid transporters in bile acid and drug disposition Handb. Exp. Pharmacol. 201 2011 169 203
32. P.A. Dawson, J. Haywood, A.L. Craddock, M. Wilson, M. Tietjen, K. Kluckman, N. Maeda, and J.S. Parks Targeted deletion of the ileal bile acid transporter eliminates enterohepatic cycling of bile acids in mice J. Biol. Chem. 278 36 2003 33920 33927
33. P.A. Dawson, T. Lan, and A. Rao Bile acid transporters J. Lipid Res. 50 12 2009 2340 2357
34. D.R. de Waart, S. Hausler, M.L. Vlaming, C. Kunne, E. Hanggi, H.J. Gruss, R.P. Oude Elferink, and B. Stieger Hepatic transport mechanisms of cholyl-L-lysyl-fluorescein J. Pharmacol. Exp. Ther. 334 1 2010 78 86
35. J.T. den Dunnen, and S.E. Antonarakis Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion Hum. Mutat. 15 1 2000 7 12
36. K. Dvorak, G.S. Watts, L. Ramsey, H. Holubec, C.M. Payne, C. Bernstein, G.J. Jenkins, R.E. Sampliner, A. Prasad, H.S. Garewal, and H. Bernstein Expression of bile acid transporting proteins in Barrett's esophagus and esophageal adenocarcinoma Am. J. Gastroenterol. 104 2 2009 302 309
37. J.J. Eloranta, D. Jung, and G.A. Kullak-Ublick The human Na+-taurocholate cotransporting polypeptide gene is activated by glucocorticoid receptor and peroxisome proliferator-activated receptor-gamma coactivator-1alpha, and suppressed by bile acids via a small heterodimer partner-dependent mechanism Mol. Endocrinol. 20 1 2006 65 79
38. J.J. Eloranta, and G.A. Kullak-Ublick The role of FXR in disorders of bile acid homeostasis Physiology (Bethesda) 23 2008 286 295
39. C.F. Fernandes, J.R. Godoy, B. Doring, M.C. Cavalcanti, M. Bergmann, E. Petzinger, and J. Geyer The novel putative bile acid transporter SLC10A5 is highly expressed in liver and kidney Biochem. Biophys. Res. Commun. 361 1 2007 26 32
40. H. Fujino, T. Saito, S. Ogawa, and J. Kojima Transporter-mediated influx and efflux mechanisms of pitavastatin, a new inhibitor of HMG-CoA reductase J. Pharm. Pharmacol. 57 10 2005 1305 1311
41. K. Gao, W.W. Lockwood, J. Li, W. Lam, and G. Li Genomic analyses identify gene candidates for acquired irinotecan resistance in melanoma cells Int. J. Oncol. 32 6 2008 1343 1349
42. J. Geyer, B. Doring, K. Meerkamp, B. Ugele, N. Bakhiya, C.F. Fernandes, J.R. Godoy, H. Glatt, and E. Petzinger Cloning and functional characterization of human sodium-dependent organic anion transporter (SLC10A6) J. Biol. Chem. 282 27 2007 19728 19741
43. J. Geyer, C.F. Fernandes, B. Doring, S. Burger, J.R. Godoy, S. Rafalzik, T. Hubschle, R. Gerstberger, and E. Petzinger Cloning and molecular characterization of the orphan carrier protein Slc10a4: expression in cholinergic neurons of the rat central nervous system Neuroscience 152 4 2008 990 1005
44. J. Geyer, T. Wilke, and E. Petzinger The solute carrier family SLC10: more than a family of bile acid transporters regarding function and phylogenetic relationships Naunyn Schmiedebergs Arch. Pharmacol. 372 6 2006 413 431
45. S.S. Glaser, and G. Alpini Activation of the cholehepatic shunt as a potential therapy for primary sclerosing cholangitis Hepatology 49 6 2009 1795 1797
46. J.R. Godoy, C. Fernandes, B. Doring, K. Beuerlein, E. Petzinger, and J. Geyer Molecular and phylogenetic characterization of a novel putative membrane transporter (SLC10A7), conserved in vertebrates and bacteria Eur. J. Cell Biol. 86 8 2007 445 460
47. Goldman, A.; Condon, A.; Adler, E.; Minnella, M.; Bernstein, C.; Bernstein, H.; Dvorak, K.; 2010. Protective effects of glycoursodeoxycholic acid in Barrett's esophagus cells. Diseases of the esophagus: official journal of the International Society for Diseases of the Esophagus/I.S.D.E 23 (2), 83-93.
48. P.M. Gonzalez, N. Hussainzada, P.W. Swaan, A.D. Mackerell Jr.; and J.E. Polli Putative irreversible inhibitors of the human sodium-dependent bile acid transporter (hASBT; SLC10A2) support the role of transmembrane domain 7 in substrate binding/translocation Pharm Res. 29 7 2012 1821 1831
49. R. Greupink, L. Dillen, M. Monshouwer, M.T. Huisman, and F.G. Russel Interaction of fluvastatin with the liver-specific Na+-dependent taurocholate cotransporting polypeptide (NTCP) Eur. J. Pharm. Sci. 44 4 2011 487 496
50. F. Grunhage, M. Jungck, C. Lamberti, H. Keppeler, U. Becker, H. Schulte-Witte, D. Plassmann, N. Friedrichs, R. Buettner, S. Aretz, T. Sauerbruch, and F. Lammert Effects of common haplotypes of the ileal sodium dependent bile acid transporter gene on the development of sporadic and familial colorectal cancer: a case control study BMC Med. Genet. 9 2008 70
51. N. Gueli, W. Verrusio, A. Linguanti, F. Di Maio, A. Martinez, B. Marigliano, and M. Cacciafesta Vitamin D: drug of the future. A new therapeutic approach Arch. Gerontol. Geriatr. 54 1 2012 222 227
52. B. Hagenbuch, and P. Dawson The sodium bile salt cotransport family SLC10 Pflugers Arch. 447 5 2004 566 570
53. E. Herraez, R.I. Macias, J. Vazquez-Tato, M. Vicens, M.J. Monte, and J.J. Marin In vitro inhibition of OATP-mediated uptake of phalloidin using bile acid derivatives Toxicol. Appl. Pharmacol. 239 1 2009 13 20
54. C. Hilgendorf, G. Ahlin, A. Seithel, P. Artursson, A.L. Ungell, and J. Karlsson Expression of thirty-six drug transporter genes in human intestine, liver, kidney, and organotypic cell lines Drug Metab. Dispos. 35 8 2007 1333 1340
55. G.M. Hirschfield, E.J. Heathcote, and M.E. Gershwin Pathogenesis of cholestatic liver disease and therapeutic approaches Gastroenterology 139 5 2010 1481 1496
56. R.H. Ho, B.F. Leake, B.L. Urquhart, J.C. Gregor, P.A. Dawson, and R.B. Kim Functional characterization of genetic variants in the apical sodium-dependent bile acid transporter (ASBT; SLC10A2) J. Gastroenterol. Hepatol. 26 12 2011 1740 1748
57. M.H. Hoang, S.J. Houng, H.J. Jun, J.H. Lee, J.W. Choi, S.H. Kim, Y.R. Kim, and S.J. Lee Barley intake induces bile acid excretion by reduced expression of intestinal ASBT and NPC1L1 in C57BL/6J mice J. Agric. Food Chem. 59 12 2011 6798 6805
58. N.J. Hu, S. Iwata, A.D. Cameron, and D. Drew Crystal structure of a bacterial homologue of the bile acid sodium symporter ASBT Nature 478 7369 2011 408 411
59. N. Hussainzada, A. Banerjee, and P.W. Swaan Transmembrane domain VII of the human apical sodium-dependent bile acid transporter ASBT (SLC10A2) lines the substrate translocation pathway Mol. Pharmacol. 70 5 2006 1565 1574
60. N. Hussainzada, T. Claro Da Silva, and P.W. Swaan The cytosolic half of helix III forms the substrate exit route during permeation events of the sodium/bile acid cotransporter ASBT Biochemistry 48 36 2009 8528 8539
61. N. Hussainzada, T.C. Da Silva, E.Y. Zhang, and P.W. Swaan Conserved aspartic acid residues lining the extracellular loop 1 of sodium-coupled bile acid transporter ASBT Interact with Na+ and 7alpha-OH moieties on the ligand cholestane skeleton J. Biol. Chem. 283 30 2008 20653 20663
62. N. Hussainzada, A. Khandewal, and P.W. Swaan Conformational flexibility of helix VI is essential for substrate permeation of the human apical sodium-dependent bile acid transporter Mol. Pharmacol. 73 2 2008 305 313
63. S. Imai, R. Kikuchi, H. Kusuhara, S. Yagi, K. Shiota, and Y. Sugiyama Analysis of DNA methylation and histone modification profiles of liver-specific transporters Mol. Pharmacol. 75 3 2009 568 576
64. D. Jung, A.C. Fantin, U. Scheurer, M. Fried, and G.A. Kullak-Ublick Human ileal bile acid transporter gene ASBT (SLC10A2) is transactivated by the glucocorticoid receptor Gut 53 1 2004 78 84
65. M. Kars, L. Yang, M.F. Gregor, B.S. Mohammed, T.A. Pietka, B.N. Finck, B.W. Patterson, J.D. Horton, B. Mittendorfer, G.S. Hotamisligil, and S. Klein Tauroursodeoxycholic acid may improve liver and muscle but not adipose tissue insulin sensitivity in obese men and women Diabetes 59 8 2010 1899 1905
66. V. Keitel, K. Cupisti, C. Ullmer, W.T. Knoefel, R. Kubitz, and D. Haussinger The membrane-bound bile acid receptor TGR5 is localized in the epithelium of human gallbladders Hepatology 50 3 2009 861 870
67. V. Keitel, and D. Haussinger Perspective: TGR5 (Gpbar-1) in liver physiology and disease 2012 Clin. Res. Hepatol. Gastroenterol.
68. C.M. Khantwal, and P.W. Swaan Cytosolic half of transmembrane domain IV of the human bile acid transporter hASBT (SLC10A2) forms part of the substrate translocation pathway Biochemistry 47 12 2008 3606 3614
69. J.Y. Kim, K.H. Kim, J.A. Lee, W. Namkung, A.Q. Sun, M. Ananthanarayanan, F.J. Suchy, D.M. Shin, S. Muallem, and M.G. Lee Transporter-mediated bile acid uptake causes Ca2+-dependent cell death in rat pancreatic acinar cells Gastroenterology 122 7 2002 1941 1953
70. R. Kohli, M. Kirby, K.D. Setchell, P. Jha, K. Klustaitis, L.A. Woollett, P.T. Pfluger, W.F. Balistreri, P. Tso, R.J. Jandacek, S.C. Woods, J.E. Heubi, M.H. Tschoep, D.A. D'Alessio, N.F. Shroyer, and R.J. Seeley Intestinal adaptation after ileal interposition surgery increases bile acid recycling and protects against obesity-related comorbidities Am. J. Physiol. Gastrointest. Liver Physiol. 299 3 2010 G652 660
71. V. Kolhatkar, L. Diao, C. Acharya, A.D. Mackerell Jr.; and J.E. Polli Identification of novel nonsteroidal compounds as substrates or inhibitors of hASBT J. Pharm. Sci. 101 1 2012 116 126
72. J.V. Kus, A. Gebremedhin, V. Dang, S.L. Tran, A. Serbanescu, and D.B. Foster Bile salts induce resistance to polymyxin in enterohemorrhagic Escherichia coli O157:H7 J. Bacteriol. 193 17 2011 4509 4515
73. J.F. Lange, J. van Gool, and G.N. Tytgat Experimental pancreatitis in the rat: role of bile reflux in sodium taurocholate-induced acute haemorrhagic pancreatitis Eur. Surg. Res. 18 6 1986 369 374
74. K.N. Lazaridis, P. Tietz, T. Wu, S. Kip, P.A. Dawson, and N.F. LaRusso Alternative splicing of the rat sodium/bile acid transporter changes its cellular localization and transport properties Proc. Natl. Acad. Sci. USA 97 20 2000 11092 11097
75. M. Le Vee, E. Jouan, B. Stieger, V. Lecureur, and O. Fardel Regulation of drug transporter expression by oncostatin M in human hepatocytes Biochem. Pharmacol. 82 3 2011 304 311
76. P. Lefebvre, B. Cariou, F. Lien, F. Kuipers, and B. Staels Role of bile acids and bile acid receptors in metabolic regulation Physiol. Rev. 89 1 2009 147 191
77. M. Leonhardt, M. Keiser, S. Oswald, J. Kuhn, J. Jia, M. Grube, H.K. Kroemer, W. Siegmund, and W. Weitschies Hepatic uptake of the magnetic resonance imaging contrast agent Gd-EOB-DTPA: role of human organic anion transporters Drug metabolism and disposition: the biological fate of chemicals 38 7 2010 1024 1028
78. A.Z. Letona, I. Niot, F. Laugerette, A. Athias, M.C. Monnot, M.P. Portillo, P. Besnard, and H. Poirier CLA-enriched diet containing t10, c12-CLA alters bile acid homeostasis and increases the risk of cholelithiasis in mice J. Nutr. 141 8 2011 1437 1444
79. Z. Li, L.B. Agellon, and D.E. Vance The role of phosphatidylethanolamine methyltransferase in a mouse model of intrahepatic cholestasis Biochim. Biophys. Acta 1811 4 2011 278 283
80. M.C. Lin, W. Kramer, and F.A. Wilson Identification of cytosolic and microsomal bile acid-binding proteins in rat ileal enterocytes J. Biol. Chem. 265 25 1990 14986 14995
81. L. Ma, M. Juttner, G.A. Kullak-Ublick, and J.J. Eloranta Regulation of the gene encoding the intestinal bile acid transporter ASBT by the caudal-type homeobox proteins CDX1 and CDX2 Am. J. Physiol. Gastrointest. Liver Physiol. 302 1 2012 G123 133
82. N.A. Martin, S.K. Mount Patrick, T.E. Estrada, H.A. Frisk, D.T. Rogan, B. Dvorak, and M.D. Halpern Active transport of bile acids decreases mucin 2 in neonatal ileum: implications for development of necrotizing enterocolitis PLoS One 6 12 2011 e27191
83. T. Miura, N. Kimura, T. Yamada, T. Shimizu, N. Nanashima, D. Yamana, K. Hakamada, and S. Tsuchida Sustained repression and translocation of Ntcp and expression of Mrp4 for cholestasis after rat 90% partial hepatectomy J. Hepatol. 55 2 2011 407 414
84. M. Miyata, H. Yamakawa, M. Hamatsu, H. Kuribayashi, Y. Takamatsu, and Y. Yamazoe Enterobacteria modulate intestinal bile acid transport and homeostasis through apical sodium-dependent bile acid transporter (SLC10A2) expression J. Pharmacol. Exp. Ther. 336 1 2011 188 196
85. H. Molina, L. Azocar, M. Ananthanarayanan, M. Arrese, and J.F. Miquel Localization of the sodium-taurocholate cotransporting polypeptide in membrane rafts and modulation of its activity by cholesterol in vitro Biochim. Biophys. Acta 1778 5 2008 1283 1291
86. M. Montagnani, A. Marangoni, A. Roda, F. Azzaroli, G. Mazzella, E. Roda, M. Tsivian, F. Neri, M. Jovani, M. Giandinoto, A. Caponi, and R. Aldini Generation of a novel antibody probe to the apical sodium-dependent bile acid transporter that inhibits ileal bile acid absorption Mol. Pharm. 6 3 2009 1012 1018
87. D.M. Moss, W.S. Kwan, N.J. Liptrott, D.L. Smith, M. Siccardi, S.H. Khoo, D.J. Back, and A. Owen Raltegravir is a substrate for SLC22A6: a putative mechanism for the interaction between raltegravir and tenofovir Antimicrob. Agents Chemother. 55 2 2011 879 887
88. J.W. Murray, A.J. Thosani, P. Wang, and A.W. Wolkoff Heterogeneous accumulation of fluorescent bile acids in primary rat hepatocytes does not correlate with their homogenous expression of ntcp Am. J. Physiol. Gastrointest. Liver Physiol. 301 1 2011 G60 68
89. W. Pan, I.S. Song, H.J. Shin, M.H. Kim, Y.L. Choi, S.J. Lim, W.Y. Kim, S.S. Lee, and J.G. Shin Genetic polymorphisms in Na+-taurocholate co-transporting polypeptide (NTCP) and ileal apical sodium-dependent bile acid transporter (ASBT) and ethnic comparisons of functional variants of NTCP among Asian populations Xenobiotica 41 6 2011 501 510
90. T.W. Pols, L.G. Noriega, M. Nomura, J. Auwerx, and K. Schoonjans The bile acid membrane receptor TGR5 as an emerging target in metabolism and inflammation J. Hepatol. 54 6 2011 1263 1272
91. R. Rais, S. Fletcher, and J.E. Polli Synthesis and in vitro evaluation of gabapentin prodrugs that target the human apical sodium-dependent bile acid transporter (hASBT) J. Pharm. Sci. 100 3 2011 1184 1195
92. O. Renner, S. Harsch, E. Schaeffeler, M. Schwab, D.M. Klass, W. Kratzer, and E.F. Stange Mutation screening of apical sodium-dependent bile acid transporter (SLC10A2): novel haplotype block including six newly identified variants linked to reduced expression Hum. Genet. 125 4 2009 381 391
93. J.M. Ridlon, D.J. Kang, and P.B. Hylemon Bile salt biotransformations by human intestinal bacteria J. Lipid Res. 47 2 2006 241 259
94. C. Root, C.D. Smith, S.S. Sundseth, H.M. Pink, J.G. Wilson, and M.C. Lewis Ileal bile acid transporter inhibition, CYP7A1 induction, and antilipemic action of 264W94 J. Lipid Res. 43 8 2002 1320 1330
95. A.J. Rose, M.B. Diaz, A. Reimann, J. Klement, T. Walcher, A. Krones-Herzig, O. Strobel, J. Werner, A. Peters, A. Kleyman, J.P. Tuckermann, A. Vegiopoulos, and S. Herzig Molecular control of systemic bile acid homeostasis by the liver glucocorticoid receptor Cell Metab. 14 1 2011 123 130
96. M.H. Saier Jr.; M.R. Yen, K. Noto, D.G. Tamang, and C. Elkan The transporter classification database: recent advances Nucleic Acids Res 37 Database issue 2009 D274 D278
97. Z. Sarwar, F. Annaba, A. Dwivedi, S. Saksena, R.K. Gill, and W.A. Alrefai Modulation of ileal apical Na+-dependent bile acid transporter ASBT by protein kinase C Am. J. Physiol. Gastrointest. Liver Physiol. 297 3 2009 G532 538
98. C.M. Schonhoff, U. Ramasamy, and M.S. Anwer Nitric oxide-mediated inhibition of taurocholate uptake involves S-nitrosylation of NTCP Am. J. Physiol. Gastrointest. Liver Physiol. 300 2 2011 G364 G370
99. B.L. Shneider, P.A. Dawson, D.M. Christie, W. Hardikar, M.H. Wong, and F.J. Suchy Cloning and molecular characterization of the ontogeny of a rat ileal sodium-dependent bile acid transporter J. Clin. Invest. 95 2 1995 745 754
100. S. Siegert, B.G. Scherf, K. Del Punta, N. Didkovsky, N. Heintz, and B. Roska Genetic address book for retinal cell types Nat. Neurosci. 12 9 2009 1197 1204
101. C.J. Soroka, A. Mennone, L.R. Hagey, N. Ballatori, and J.L. Boyer Mouse organic solute transporter alpha deficiency enhances renal excretion of bile acids and attenuates cholestasis Hepatology 51 1 2010 181 190
102. C.J. Soroka, H. Velazquez, A. Mennone, N. Ballatori, and J.L. Boyer Ostalpha depletion protects liver from oral bile acid load Am. J. Physiol. Gastrointest. Liver Physiol. 301 3 2011 G574 G579
103. P.L. Splinter, K.N. Lazaridis, P.A. Dawson, and N.F. LaRusso Cloning and expression of SLC10A4, a putative organic anion transport protein World J. Gastroenterol. 12 42 2006 6797 6805
104. S. Sreedharan, O. Stephansson, H.B. Schioth, and R. Fredriksson Long evolutionary conservation and considerable tissue specificity of several atypical solute carrier transporters Gene 478 1-2 2011 11 18
105. B. Stieger The role of the sodium-taurocholate cotransporting polypeptide (NTCP) and of the bile salt export pump (BSEP) in physiology and pathophysiology of bile formation Handb. Exp. Pharmacol. 201 2011 205 259
106. C. Stross, A. Helmer, K. Weissenberger, B. Gorg, V. Keitel, D. Haussinger, and R. Kubitz Protein kinase C induces endocytosis of the sodium taurocholate cotransporting polypeptide Am. J. Physiol. Gastrointest. Liver Physiol. 299 2 2010 G320 G328
107. D.G. Thanassi, L.W. Cheng, and H. Nikaido Active efflux of bile salts by Escherichia coli J. Bacteriol. 179 8 1997 2512 2518
108. S. Tolle-Sander, K.A. Lentz, D.Y. Maeda, A. Coop, and J.E. Polli Increased acyclovir oral bioavailability via a bile acid conjugate Mol. Pharm. 1 1 2004 40 48
109. A. Tonjes, H. Wittenburg, J. Halbritter, O. Renner, S. Harsch, E.F. Stange, F. Lammert, M. Stumvoll, and P. Kovacs Effects of SLC10A2 variant rs9514089 on gallstone risk and serum cholesterol levels- meta-analysis of three independent cohorts BMC Med. Genet. 12 2011 149
110. P.J. Trivedi, and S. Ward Altered bile acid pool using IBAT inhibitors for constipation: a potentially increased risk of malignancy Am. J. Gastroenterol. 107 1 2012 140
111. A. Tzschach, C. Ramel, A. Kron, B. Seipel, C. Wuster, U. Cordes, T. Liehr, M. Hoeltzenbein, C. Menzel, H.H. Ropers, R. Ullmann, V. Kalscheuer, J. Decker, and D. Steinberger Hypergonadotropic hypogonadism in a patient with inv ins (2;4) Int. J. Androl. 32 3 2009 226 230
112. G. Vassileva, A. Golovko, L. Markowitz, S.J. Abbondanzo, M. Zeng, S. Yang, L. Hoos, G. Tetzloff, D. Levitan, N.J. Murgolo, K. Keane, H.R. Davis Jr.; J. Hedrick, and E.L. Gustafson Targeted deletion of Gpbar1 protects mice from cholesterol gallstone formation Biochem. J. 398 3 2006 423 430
113. W.E. Visser, W.S. Wong, A.A. van Mullem, E.C. Friesema, J. Geyer, and T.J. Visser Study of the transport of thyroid hormone by transporters of the SLC10 family Mol. Cell. Endocrinol. 315 1-2 2010 138 145
114. M. Wagner, G. Zollner, and M. Trauner Nuclear receptors in liver disease Hepatology 53 3 2011 1023 1034
115. H.M. Wain, E.A. Bruford, R.C. Lovering, M.J. Lush, M.W. Wright, and S. Povey Guidelines for human gene nomenclature Genomics 79 4 2002 464 470
116. M.H. Wong, P. Oelkers, A.L. Craddock, and P.A. Dawson Expression cloning and characterization of the hamster ileal sodium-dependent bile acid transporter J. Biol. Chem. 269 2 1994 1340 1347
117. X. Xia, H. Francis, S. Glaser, G. Alpini, and G. LeSage Bile acid interactions with cholangiocytes World J. Gastroenterol. 12 22 2006 3553 3563
118. S.B. Yanni, P.B. Smith, D.K. Benjamin Jr.; P.F. Augustijns, D.R. Thakker, and P.P. Annaert Higher clearance of micafungin in neonates compared with adults: role of age-dependent micafungin serum binding Biopharm. Drug Dispos. 32 4 2011 222 232
119. X. Zheng, L. Diao, S. Ekins, and J.E. Polli Why we should be vigilant: drug cytotoxicity observed with in vitro transporter inhibition studies Biochem. Pharmacol. 80 7 2009 1087 1092
120. X. Zheng, S. Ekins, J.P. Raufman, and J.E. Polli Computational models for drug inhibition of the human apical sodium-dependent bile acid transporter Mol. Pharm. 6 5 2009 1591 1603
121. X. Zheng, and J.E. Polli Synthesis and in vitro evaluation of potential sustained release prodrugs via targeting ASBT Int. J. Pharm. 396 1-2 2010 111 118
122. Q. Zhou, J. Li, H. Wang, Y. Yin, and J. Zhou Identification of nigral dopaminergic neuron-enriched genes in adult rats Neurobiol. Aging 32 2 2011 313 326